Market Scope
Market Research Future (MRFR) studied the global antibiotics market 2021 for the review period till 2030. As per MRFR analysis, the market of antibiotics is likely to register 4.8% CAGR over the analysis period. By 2030, the antibiotics market value is expected to touch USD 51,835 Mn by.
Drivers and Restrains Impacting Antibiotics Market
The surge in cases of bacterial infections is creating the demand for antibiotics that can support the expansion of the market. The increase in cases of COVID 19 and sepsis induced by COVID-19 can boost the demand for high power antibiotics, which, in turn, can prompt the market expansion. The availability of different type of antibiotics, one which can stop bacteria from reproducing and another that can destroy them, across different countries to meet treatment requirements of patient can improve the impetus of the antibiotics market.
increasing efforts by major companies for the formulation of advanced antibiotic products, rise in approval of antibiotic drugs, development of generic drugs, increasing incidence of infectious and chronic diseases, availability of investment opportunities by biotech companies for research and development of effective biotech antibiotics, are other causes that can contribute to the upsurge of the global antibiotics market in the near future. In addition, numerous marketers that are dominating the global antibiotics market are involved in launching product and in strategic collaborations to strengthen their global footprint. The change in competitive landscape can cast a positive impact on the antibiotics market.
Key Players of Antibiotics Market
Astellas Pharma Inc. (Japan), Novartis AG (Switzerland), Pfizer Inc. (US), Bristol-Myers Squibb Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Sanofi (France), Johnson & Johnson Services, Inc. (US), GlaxoSmithKline PLC (UK), Abbott Laboratories (US), Merck & Co., Inc. (US), Bayer AG (Germany), and Eli Lilly and Company (US) are some reputed companies in the global antibiotics market that are profiled by MRFR in the recent report.
Segment Analysis of Antibiotics Market
The segments study of the global antibiotics market is based on drug class, drug origin, spectrum of activity, and end user.
The drug class-based segments of the antibiotic market are cephalosporins, macrolides, penicillin, carbapenem, fluoroquinolones, sulfonamides, and aminoglycosides among others. The segment of carbapenem is likely to thrive at the highest pace in review term owing to the rising incidence of pneumonia and, urinary tract infections that require antibiotics. The surge in the utility of carbapenem class of antibiotics can substantially drive the antibiotics market growth in the years ahead.
The spectrum of activity-based segments of the antibiotics market are narrow-spectrum antibiotics and broad-spectrum antibiotics. The segment of broad-spectrum antibiotic is likely to hold the largest share of the global market as broad-spectrum antibiotic not only fight against microbial resistance, but also act against a wide range of diseases.
The drug origin-based segments of the antibiotics market are synthetic, natural, and semisynthetic. The segment of semisynthetic is likely to rise at a healthy CAGR as semi-synthetic antibiotics have fewer side-effects and can act against a broader spectrum of disease.
The end user-based segments of the antibiotics market are research organizations, and hospitals & clinics among others. The segment of hospitals and clinics is anticipated to rise at a decent growth rate as a large number of treatments and majority of surgical procedures are carried out at hospitals, which boost the demand for antibiotics, thus support expansion of the antibiotics market in the approaching years.
Regional Study of Antibiotics Market
The market of antibiotics is studied for the Americas, Europe, Asia-Pacific, and the Middle East Asia & Africa for regional insights. land is anticipated to be the biggest market due to the increasing adoption of antibiotics. The antibiotics market within the Americas has more been branched into North America and Latin America, with the North yank market divided into the U.S.A. and Canada. EU antibiotics market has been classified as Western Europe and jap Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the remainder of Western Europe. The antibiotics market in Asia-Pacific has been divided into Japan, China, India, South Korea, Australia, and therefore the remainder of Asia-Pacific. straightforward convenience of antibiotic medication and the rise in over-the-counter antibiotic medicines has boosted the expansion of the antibiotics market, the market in Asia-Pacific is anticipated to be the fastest-growing. The antibiotics market within MEA has been divided into the center East and Africa.v
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
